549 related articles for article (PubMed ID: 25064351)
21. Synthesis and in vitro antitumor activities of novel 4-anilinoquinazoline derivatives.
Chandregowda V; Kush AK; Chandrasekara Reddy G
Eur J Med Chem; 2009 Jul; 44(7):3046-55. PubMed ID: 18771819
[TBL] [Abstract][Full Text] [Related]
22. Design, Synthesis, and Biological Evaluation of Novel Quinazoline Derivatives Possessing a Trifluoromethyl Moiety as Potential Antitumor Agents.
Chen M; Cheng S; Dai X; Yu J; Wang H; Xu B; Luo H; Xu G
Chem Biodivers; 2024 May; 21(5):e202301776. PubMed ID: 38602834
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and in vitro antitumor evaluation of primary amine substituted quinazoline linked benzimidazole.
Paul K; Sharma A; Luxami V
Bioorg Med Chem Lett; 2014 Jan; 24(2):624-9. PubMed ID: 24360999
[TBL] [Abstract][Full Text] [Related]
24. Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties.
Conconi MT; Marzaro G; Urbani L; Zanusso I; Di Liddo R; Castagliuolo I; Brun P; Tonus F; Ferrarese A; Guiotto A; Chilin A
Eur J Med Chem; 2013 Sep; 67():373-83. PubMed ID: 23900004
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL
Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and cytotoxicity of 2-phenylquinazolin-4(3H)-one derivatives.
Rhee HK; Yoo JH; Lee E; Kwon YJ; Seo HR; Lee YS; Choo HY
Eur J Med Chem; 2011 Sep; 46(9):3900-8. PubMed ID: 21704436
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of novel pyrimidine-benzimidazol hybrids as potential anticancer agents.
Shao KP; Zhang XY; Chen PJ; Xue DQ; He P; Ma LY; Zheng JX; Zhang QR; Liu HM
Bioorg Med Chem Lett; 2014 Aug; 24(16):3877-81. PubMed ID: 25001482
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, single crystal and antitumor activities of benzimidazole-quinazoline hybrids.
Sharma A; Luxami V; Paul K
Bioorg Med Chem Lett; 2013 Jun; 23(11):3288-94. PubMed ID: 23611732
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and biological evaluation of novel quinazoline derivatives as potential antitumor agents: molecular docking study.
El-Azab AS; Al-Omar MA; Abdel-Aziz AA; Abdel-Aziz NI; el-Sayed MA; Aleisa AM; Sayed-Ahmed MM; Abdel-Hamide SG
Eur J Med Chem; 2010 Sep; 45(9):4188-98. PubMed ID: 20599299
[TBL] [Abstract][Full Text] [Related]
30. Synthesis, and docking studies of some fused-quinazolines and quinazolines carrying biological active isatin moiety as cell-cycle inhibitors of breast cancer cell lines.
Radwan AA; Alanazi FK; Al-Dhfyan A
Drug Res (Stuttg); 2013 Mar; 63(3):129-36. PubMed ID: 23444171
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and antitumor activity of novel 2-(1-substituted-piperidin-4-ylamino)quinazolines as antitumor agents.
Wang YK; Jin J; Zhu LN; Zhang Y; Chen XG; Gao XQ; Xu BL
Yao Xue Xue Bao; 2012 Sep; 47(9):1164-78. PubMed ID: 23227546
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, Molecular Modeling and Biological Evaluation of 4-Alkoxyquinazoline Derivatives as Novel Inhibitors of VEGFR2.
Lu L; Zhao TT; Liu TB; Sun WX; Xu C; Li DD; Zhu HL
Chem Pharm Bull (Tokyo); 2016 Nov; 64(11):1570-1575. PubMed ID: 27568484
[TBL] [Abstract][Full Text] [Related]
33. Preparation, Characterization and In Vitro Biological Evaluation of Novel Curcumin Derivatives as Cytotoxic and Apoptosis-Inducing Agents.
Arjomandi OK; Almasi S; Hosseinzadeh L; Kavoosi M; Adibi H
Anticancer Agents Med Chem; 2021; 21(10):1309-1322. PubMed ID: 33006540
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.
Duan YC; Ma YC; Zhang E; Shi XJ; Wang MM; Ye XW; Liu HM
Eur J Med Chem; 2013 Apr; 62():11-9. PubMed ID: 23353743
[TBL] [Abstract][Full Text] [Related]
35. Halogenated flavanones as potential apoptosis-inducing agents: synthesis and biological activity evaluation.
Safavi M; Esmati N; Ardestani SK; Emami S; Ajdari S; Davoodi J; Shafiee A; Foroumadi A
Eur J Med Chem; 2012 Dec; 58():573-80. PubMed ID: 23174316
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and biological evaluation of 7-O-modified oroxylin A derivatives.
Fu W; Wang J; Yu L; Zhao L; Lu N; You Q; Guo Q; Li Z
Bioorg Med Chem Lett; 2012 Jan; 22(2):1118-21. PubMed ID: 22196122
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and biological activities of novel oxazolo[4,5-g]quinazolin-2(1H)-one derivatives as EGFR inhibitors.
Yin S; Zhou L; Lin J; Xue L; Zhang C
Eur J Med Chem; 2015 Aug; 101():462-75. PubMed ID: 26188620
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, biological evaluation and docking study of novel quinazoline derivatives as EGFR-TK inhibitors.
Jin H; Wu BX; Zheng Q; Hu CH; Tang XZ; Zhang W; Rao GW
Future Med Chem; 2021 Apr; 13(7):601-612. PubMed ID: 33685233
[No Abstract] [Full Text] [Related]
39. Synthesis and evaluation of 4-anilinoquinazoline bioisosteres as potential anti-breast cancer agents.
El-Ansary AK; Kamal AM; Al-Ghorafi MA
Eur J Med Chem; 2014 Oct; 86():202-10. PubMed ID: 25151582
[TBL] [Abstract][Full Text] [Related]
40. Discovery of 6-substituted 4-anilinoquinazolines with dioxygenated rings as novel EGFR tyrosine kinase inhibitors.
Li DD; Fang F; Li JR; Du QR; Sun J; Gong HB; Zhu HL
Bioorg Med Chem Lett; 2012 Sep; 22(18):5870-5. PubMed ID: 22901387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]